Welcome to LookChem.com Sign In|Join Free
  • or
2H-1,4-Benzodiazepin-2-one, 7-bromo-1,3-dihydro-3-methyl-5-phenyl-, (3S)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

872873-92-2

Post Buying Request

872873-92-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

872873-92-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 872873-92-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,2,8,7 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 872873-92:
(8*8)+(7*7)+(6*2)+(5*8)+(4*7)+(3*3)+(2*9)+(1*2)=222
222 % 10 = 2
So 872873-92-2 is a valid CAS Registry Number.

872873-92-2Downstream Products

872873-92-2Relevant academic research and scientific papers

SELECTIVE ANTICONVULSANT AGENTS AND THEIR USES

-

, (2010/11/03)

In preferred embodiments, the present invention provides methods of treatment and pharmaceutical compositions for the suppression, alleviation and prevention of seizures. The preferred embodiments of the present invention further relate to methods of treatment and pharmaceutical compositions using benzodiazepine derivatives that provide suppression, alleviation and prevention of seizures with reduced sedative and ataxic side effects.

Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects

-

Page/Page column 56-57, (2008/06/13)

The present invention provides compositions and methods of using stereospecific benzodiazepine derivatives, their salts and prodrugs for the treatment of anxiolytic or convulsant disorders having the side effects of reduced alcohol craving in human alcoholics and a concomitant reduced sedative, hypnotic, muscle relaxant and ataxic side-effects. The invention further provides pharmaceutical compositions for treatment of anxiolytic and convulsant disorders in subjects in need thereof, comprising a compound, prodrug or a salt having a chemical structure represented by any one of Formula I-XXI and a pharmaceutically-acceptable carrier.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 872873-92-2